Results 261 to 270 of about 36,244 (312)

Effectiveness of COVID-19 Vaccines in Mahabad, Iran: A Cohort Study. [PDF]

Arch Razi Inst
Nasrin P, Shaker S, Mohammad H.
europepmc   +1 more source

Dynamic chromium dopant promotes interfacial water activation on cobalt spinel oxide for efficient oxygen evolution in acid. [PDF]

Nat Commun
Wu L, Zhao B, Huang W, Li D, Liao Z, Chen Y, Yao N, Zhou H, Luo W.   +8 more
europepmc   +1 more source

Adverse events of special interest after vaccination with COVID-19 vaccines: a cohort event monitoring study in Iran. [PDF]

Eur J Med Res
Aliyari R, Emamian MH, Mahdavi S, Enayatrad M, Sahab-Negah S, Nili S, Fereidouni M, Mangolian Shahrbabaki P, Ansari-Moghadam A, Shahraki-Sanavi F, Fateh M, Khajeha H, Emamian Z, Behmanesh E, Sharifi H.   +14 more
europepmc   +1 more source

Ultrahigh current output performance in piezoelectric energy harvesters enabled by phase boundary-bandgap synergistic engineering. [PDF]

Nat Commun
Lin Y, Wu Y, Zheng M, Wu B, Zhao C, Wu C, Wang K, Hou Y.   +7 more
europepmc   +1 more source

COVID-19 vaccine immunogenicity in Mongolian adults with and without chronic hepatitis. [PDF]

BMC Infect Dis
Callier V, Jargalsaikhan G, Batkhuu M, Ridzon R, Hunsberger S, Sereti I, Shaw-Saliba K, Weyers S, Francis A, Dashdorj N.   +9 more
europepmc   +1 more source

Durability of protection of ancestral-strain COVID-19 third- and fourth-dose vaccine boosters against Omicron XBB/XBB.1 and JN.1 symptomatic infection, hospitalisation and mortality in Indonesian adults (2023-2024): a test-negative case-control study. [PDF]

Lancet Reg Health Southeast Asia
Wiratama BS, Oktaria V, Indrihutami K, Hardhantyo M, Maula AW, Djasri H, Dinari R, Syairaji M, Suwarti, Pradipta A, Nusantara DU, Kusumaningrum A, Andrew, Tamburian MM, Baehaqi IS, Merrill R, Surendra H, Wijayanti F, Dahl BA, Hamers RL.   +19 more
europepmc   +1 more source

Side effects and perceptions following Sinopharm COVID-19 vaccination [PDF]

International Journal of Infectious Diseases, 2021
Abstract Background Vaccines are one of the best interventions developed for eradicating COVID-19, the rapid creation of vaccinations was increased the risk of vaccine safety problems. The aim of this study to provide evidence on Sinopharm COVID-19 vaccine side effects which is approved by the United
Balsam Qubais Saeed, Shaikha Salah Alhaj, Zainab Mansour Alkokhardi   +2 more
exaly   +6 more sources

Comparison of AstraZeneca and sinopharm vaccines as boosters in protection against COVID-19 infection

Biologicals, 2023
As the global number of confirmed cases rises past 640 million, vaccination remains the most effective measure in controlling COVID-19. Studies have shown that two doses of vaccination can significantly reduce hospitalization and mortality rates among patients, but the effectiveness of booster doses is also important.
Arash Letafati
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Sinopharm (BBIBP-CorV) COVID-19 Vaccination in Hemodialysis Patients and Healthy Individuals: 1-year Effectiveness and Immunogenicity Immunization of Sinopharm Vaccine against COVID-19

Medical Research Archives
Introduction: The COVID-19 pandemic has presented significant challenges for immunocompromised populations, particularly hemodialysis patients, who are at an elevated risk for severe outcomes. Vaccination remains a critical strategy to mitigate these risks. This study evaluates the 1-year effectiveness and immunogenicity of the Sinopharm (BBIBP-CorV)
Seyed Naini, Yasaman Baseri, Azadeh Koomleh, Niloofar Fakour, Aryan Salahi-Niri, Mahsa Niasar, Yeganeh Farsi, Mohamad Pourhoseingholi, Seyed Mohebbi, Mohsen Nafar, Ali Akbar Amirzargar, Shiva Samavat, Marieh Moghaddam   +12 more
openaire   +2 more sources